Carotid artery stenting: a single-center experience

Carotid artery stenting has emerged as a non-surgical option for treating carotid artery disease. Prior research has shown that surgical endarterectomy remains the gold standard for many patients. However, some individuals are not suitable surgical candidates due to high risk. This gap motivated the exploration of stenting as a safer alternative. No prior work had resolved whether stenting could match surgical outcomes in high-risk populations. Established knowledge includes the risks of stroke and mortality associated with traditional surgery. This paper's contribution is to evaluate stenting's safety and effectiveness in a high-risk cohort. The study addresses uncertainty about the role of operator experience in outcomes. It also examines whether stenting can reduce access-site complications compared to surgery.

The aim of this study was to assess the safety and outcomes of carotid artery stenting in a high-risk patient group. The specific problem addressed is whether stenting can provide acceptable results in patients unsuitable for surgery. The motivation stems from the limitations of surgical endarterectomy in high-risk individuals. The study also sought to determine if operator experience influences complication rates. Researchers focused on stroke, death, and myocardial infarction as primary outcomes. They also examined access-site complications and contrast-induced nephropathy. The need for a non-surgical alternative in high-risk patients drove this investigation. The study's design allowed for comparison between early and later patient groups to assess learning effects.

The study involved 40 patients undergoing carotid stenting at a single center. Participants were divided into two groups based on treatment order. Group 1 included the first 20 patients, and Group 2 included the remaining 20. Researchers used various embolic protection devices and carotid stents. Technical success was defined as successful stent deployment without major complications. Outcomes assessed included stroke, death, myocardial infarction, access-site complications, and nephropathy. Follow-up averaged 12 months to monitor long-term effects. Data collection focused on in-hospital and post-discharge events. The study design allowed for comparison between groups to evaluate the impact of experience.

The overall technical success rate was 100% across all patients. The in-hospital stroke or death rate was 7.5%, with three events: two deaths and one major stroke. Group 1 had a 10% complication rate (2/20), while Group 2 had a 5% rate (1/20). This difference was not statistically significant (p = 0.09). No access-site complications occurred in any patient. Mild contrast-induced nephropathy affected 3 patients (7.5%). During follow-up, no major strokes or neurological deaths occurred. These findings suggest that stenting is feasible and relatively safe in high-risk patients.

The authors propose that carotid stenting is a feasible and relatively safe option for high-risk patients. They suggest that the learning curve may influence early complication rates but not significantly. The absence of access-site complications supports stenting over surgery in certain cases. The low rate of major strokes and deaths during follow-up suggests acceptable long-term outcomes. The authors do not claim stenting is superior to surgery but suggest it is a viable alternative. They propose that operator experience may improve outcomes but did not reach statistical significance here. The findings suggest that stenting can be considered in patients unsuitable for surgery. The authors emphasize the need for further studies to confirm these results.